Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Prostanoids are a group of bioactive lipids working as local mediators and include D, E, F and I types of prostaglandins (PGs) and thromboxanes. Prostacyclin (PGI2) acts on platelets and blood vessels to inhibit platelet aggregation and to cause vasodilatation, and is thought to be important for vascular homeostasis. Aspirin-like drugs, including indomethacin, which inhibit prostanoid biosynthesis, suppress fever, inflammatory swelling and pain, and interfere with female reproduction, suggesting that prostanoids are involved in these processes, although it is not clear which prostanoid is the endogenous mediator of a particular process. Prostanoids act on seven-transmembrane-domain receptors which are selective for each type. Here we disrupt the gene for the prostacyclin receptor in mice by using homologous recombination. The receptor-deficient mice are viable, reproductive and normotensive. However, their susceptibility to thrombosis is increased, and their inflammatory and pain responses are reduced to the levels observed in indomethacin-treated wild-type mice. Our results establish that prostacyclin is an antithrombotic agent in vivo and provide evidence for its role as a mediator of inflammation and pain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, M. J., & de Beer, E. J. (1959) · Cited by 2,671
ACETIC ACID FOR ANALGESIC SCREENING
KOSTER, R., Anderson, W. N., & de Beer, E. J. (1959) · Medical Entomology and Zoology · Cited by 2,132
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108 · cited 1×
“The generation of chimaeras and mutant mice has been describe”
BackgroundSelf-citationProstaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082 · cited 1×
“A similar abnormal mendelian ratio of male F 2 progeny was reported for cyclooxygenase-2-deficient mic”
BackgroundMalmberg, A. B., & Yaksh, T. L. (1992) · Science · doi:10.1126/science.1381521 · Cited by 710 · cited 1×
“but also by facilitating pain transmission at the spina”
BackgroundThe Role of Arachidonic Acid Oxygenation Products in Pain and Inflammation
Davies, P. (1984) · Annual Review of Immunology · doi:10.1146/annurev.immunol.2.1.335 · Cited by 467
Rat model of arterial thrombosis induced by ferric chloride
Kurz, K. D., Main, B. W., & Sandusky, G. E. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90106-m · Cited by 431 · cited 1×
“5% FeCl 3 solution, a procedure known to injure the endotheliu”
Background
Cited by
Items 301–400 of 783
Therapeutic Inhibition of Platelet Function in Stroke
Harker, L. A. (1998) · Cerebrovascular Diseases · doi:10.1159/000047513 · Cited by 51
“Thus, the results of biochemical studies on its mechanism of action, the lack of dose-response relationship in clinical studies evaluating its antithrombotic effects, and the dose-dependence of its side effects all support the use of the lowest effective dose of aspirin preventing various thromboembolic disorders [”
BackgroundMiggin, S. M., & Kinsella, B. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203353200 · Cited by 51
RetractedMore pieces of the platelet activation puzzle slide into place
Brass, L. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8944 · Cited by 51
A novel human pain insensitivity disorder caused by a point mutation in ZFHX2
Habib, A. M., Matsuyama, A., Okorokov, A. L., Santana-Varela, S., Bras, J. T., Aloisi, A. M., Emery, E. C., Bogdanov, Y. D., Follenfant, M., Gossage, S. J., et al. (2018) · Brain · doi:10.1093/brain/awx326 · Cited by 50
Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition
Li, X., Suo, P., Wang, Y., Zou, L., Nie, X.-L., Zhao, Y., & Miao, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1365802 · Cited by 58
Immunomodulatory properties of Xylaria nigripes in peritoneal macrophage cells of Balb/c mice
Ko, H.-J., Ai-rong, S., Lai, M., & Ng, L. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.10.022 · Cited by 50
Yuhki, K., Kojima, F., Yamada, T., Fujino, T., Hara, A., Takayama, K., Maruyama, T., Yoshida, A., Narumiya, S., Kuriyama, S., et al. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-01-0043 · Cited by 50
Self-citationNMDA receptor-dependent long term hyperalgesia after tail amputation in mice
Zhuo, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00197-6 · Cited by 52
Cyclooxygenase-2-derived endogenous prostacyclin enhances mouse embryo hatching
Huang, J.-C., Wun, W.-S. A., Goldsby, J. S., Matijevic‐Aleksic, N., & Wu, K. K. (2004) · Human Reproduction · doi:10.1093/humrep/deh524 · Cited by 50
“, 2002) and PGI2 receptor- (Murata et al., 1997) deficient mice has not been compared with that of the wild-types.”
InfluentialProstaglandins in the kidney: developments since Y2K
Nasrallah, R., Clark, J., & Hébert, R. (2007) · Clinical Science · doi:10.1042/cs20070089 · Cited by 57
Pain modulators regulate the dynamics of PKA-RII phosphorylation in subgroups of sensory neurons
Isensee, J., Diskar, M., Waldherr, S., Buschow, R., Hasenauer, J., Prinz, A., Allgöwer, F., Herberg, F., & Hucho, T. (2014) · Journal of Cell Science · doi:10.1242/jcs.136580 · Cited by 44
“Mice deficient for the PGI2 receptor showed reduced inflammation and pain comparable with that of NSAID treatment in models of acute and chronic inflammation (Murata et al., 1997; Pulichino et al., 2006).”
ResultSheikh, B. Y., Zihad, S. M. N. K., Sifat, N., Uddin, S. J., Shilpi, J. A., Hamdi, O. A. A., Hossain, H., Rouf, R., & Jahan, I. A. (2016) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-016-0239-5 · Cited by 49
Kanda, H., Kobayashi, K., Yamanaka, H., Okubo, M., & Noguchi, K. (2017) · eneuro · doi:10.1523/eneuro.0064-17.2017 · Cited by 47
“Previous reports showed that PGI2 plays a role in pain and inflammation via the IP receptor under pathologic conditions (Murata et al., 1997; Schuh et al., 2013).”
BackgroundProstanoid function and cardiovascular disease
Iñiguez, M. A., Cacheiro‐Llaguno, C., Cuesta, N., Díaz‐Muñoz, M. D., & Fresno, M. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802180882 · Cited by 57
“However, after endothelial damage they show an enhanced thrombotic response compared to control littermates (Murata et al., 1997), indicating that PGI2 does play a major role only in response to stress and not in the basal systemic circulation.”
BackgroundOkada, Y., Hara, A., Ma, H., Xiao, C., Takahata, O., Kohgo, Y., Narumiya, S., & Ushikubi, F. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703627 · Cited by 49
Self-citationIs mPGES-1 a promising target for pain therapy?
Scholich, K., & Geißlinger, G. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.001 · Cited by 48
Polagruto, J. A., Schramm, D. D., Wang, J. F., Lee, L., & Keen, C. L. (2003) · Journal of Medicinal Food · doi:10.1089/109662003772519840 · Cited by 48
Cheng, L., Jia, H., Löhr, M., Bagherzadeh, A., Holmes, D. I. R., Selwood, D., & Zachary, I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402488200 · Cited by 47
Discovery and SAR development of 2-(phenylamino) imidazolines as postacyclin receptor antagonists
Clark, R. D., Jahangir, A. M., Severance, D. L., Salazar, R., Chang, T., Chang, D. J., Jett, M. F., Smith, S., & Bley, K. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.10.070 · Cited by 47
CNS DEPRESSANT EFFECT OF THE CRUDE ETHANOLIC EXTRACT OF THE FLOWERING TOPS OF ROSA DAMASCENA
Nyeem, A. B., Alam, M. A., Awal, M., Mostofa, M., Uddin, S. J., Islam, N., & Rouf, R. (2006) · Iranian journal of pharmacology & therapeutics · Cited by 47
Yuhki, K., Ueno, A., Naraba, H., Kojima, F., Ushikubi, F., Narumiya, S., & Oh‐ishi, S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071548 · Cited by 47
“Accordingly, we previously demonstrated that PGI2 plays major roles in inflammatory pain and edema formation using mice lacking PGI2 receptor IP (Murata et al., 1997; Ueno et al., 2000).”
BackgroundMethodSelf-citationEicosanoids: lipid mediators of inflammation in transplantation
Rocha, P. N., Plumb, T. J., & Coffman, T. M. (2003) · Springer Seminars in Immunopathology · doi:10.1007/s00281-003-0132-4 · Cited by 49
“Along with its vascular effects, generation and characterization of IP-deficient knockout mice has revealed an unexpected role for IP receptors in mediating pain responses [37].”
BackgroundTakahashi, C., Muramatsu, R., Fujimura, H., Mochizuki, H., & Yamashita, T. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.335 · Cited by 44
“Furthermore, no morphological or histological abnormalities were detected.(39) Meanwhile, IP receptordeficient mice showed slightly altered responses to acute nociceptive stimuli,(39) suggesting that the role of endogenous prostacyclin-IP receptor signaling is restricted to pathological conditions.”
BackgroundComprehensive mammalian genetics: history and future prospects of gene trapping in the mouse
Zambrowicz, B., & Friedrich, G. A. (1998) · The International Journal of Developmental Biology · doi:10.1387/ijdb.9853834 · Cited by 46
“An illustrative example is the mutation in the prostacyclin receptor generated in a line of mice by Murata et al. (1997).”
BackgroundAspirin and spinal haematoma after neuraxial anaesthesia: Myth or reality?
Vela-Vásquez, R. N., & Romero, R. (2015) · British Journal of Anaesthesia · doi:10.1093/bja/aev348 · Cited by 48
Suzuki, M., Noyori, R., Långström, B., & Watanabe, Y. (2000) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.73.1053 · Cited by 45
Prostaglandins in pathogenesis and treatment of multiple sclerosis
Mirshafiey, A., & Jadidi‐Niaragh, F. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923971003667627 · Cited by 47
“IP receptor knockout mice did not show any alteration in their nociceptive reflexes examined by hot plate and tail flick tests, indicating that PGI2 is not involved in the nociceptive neurotransmission at the spinal and supraspinal levels.((105)) Recent studies indicated that IP receptor signaling suppresses Th2-media…”
BackgroundYoshida, T., Sawa, T., Ishiguro, T., Horiba, A., Minatoguchi, S., & Fujiwara, H. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-008-0508-z · Cited by 45
Identifying pain genes: Bottom-up and top-down approaches
Mogil, J. S., & McCarson, K. E. (2000) · Journal of Pain · doi:10.1054/jpai.2000.9821 · Cited by 49
Patrono, C., & Baigent, C. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.696 · Cited by 44
“succeeded in generating mice deficient in the IP receptor whose phenotype suggested an important role for PGI2 in mediating inflammation and in protecting against thrombosis.(23) The second unexpected finding came from a large GI outcome trial, VIGOR, a prospective, randomized, double-blind comparison of rofecoxib (50…”
BackgroundThe role of the cylooxygenase pathway in nociception and pain
Bingham, S., Beswick, P., Blum, D., Gray, N. M., & Chessell, I. P. (2006) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2006.09.001 · Cited by 51
Role of Transient Receptor Potential and Acid-sensing Ion Channels in Peripheral Inflammatory Pain
White, J. P. M., Cibelli, M., Fidalgo, A. R., Paule, C. C., Noormohamed, F. H., Urbán, L., Maze, M., & Nagy, I. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181ca3179 · Cited by 44
Giguère, V., Gallant, M. A., de Brum-Fernandes, A. J., & Parent, J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.041 · Cited by 44
Lévy, M., Huang, L. J., Rossi, E., Blandinières, A., Israël‐Biet, D., Gaussem, P., Bischoff, J. E., & Smadja, D. M. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-11-0907 · Cited by 43
“PGI2 or prostacyclin analogues have also been involved in ischaemia-reperfusion injury, in particular in heart and liver transplantation (3, 4) and are important mediators of acute inflammation and inflammatory pain transmission (5, 6).”
BackgroundHuman prostacyclin receptor structure and function from naturally-occurring and synthetic mutations
Stitham, J., Arehart, E. J., Gleim, S., Douville, K. L., & Hwa, J. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.010 · Cited by 43
Patrignani, P., Febbo, C. D., Tacconelli, S., Douville, K. L., Guglielmi, M. D., Horvath, R. J., Ding, M., Sierra, K., Stitham, J., Gleim, S., et al. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328301a774 · Cited by 43
Suzuki, M., Doi, H., Hosoya, T., Långström, B., & Watanabe, Y. (2004) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2004.06.003 · Cited by 43
Osanai, T., Kamada, T., Fujiwara, N., Katoh, T., Takahashi, K., Kimura, M., Satoh, K., Magota, K., Kodama, S., Tanaka, T., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31778 · Cited by 43
Self-citationArachidonic acid pathways in nociception.
Smith, H. S. (2006) · PubMed · Cited by 42
Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice
Chen, L., Yang, G., Monslow, J., Todd, L., Cormode, D. P., Tang, J., Grant, G. R., DeLong, J. H., Tang, S. Y., Lawson, J. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401797111 · Cited by 47
“The predisposition to thrombosis and hypertension observed in mice treated with COX-2 inhibitors (29, 30) or lacking the IP (31) is absent in mPGES-1 KO mice (32) and a similar contrast is evident when deletion of COX-2 vs.”
BackgroundInduction of Prostacyclin/PGI2 Synthase Expression After Cerebral Ischemia–Reperfusion
Fang, Y.-C., Wu, J., Chen, J.-J., Cheung, W.-M., Tseng, P., Tarn, K.-B., Shyue, S., Chen, J.-J., & Lin, T. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600205 · Cited by 44
“Mice lacking IP developed larger ischemic myocardial infarction and less pain sensation than wild-type mice, which were independent of PGI2’s effects on platelets (Murata et al, 1997; Xiao et al, 2001).”
BackgroundBélichard, P., Landry, M., Faye, P., Bachvarov, D. R., Bouthillier, J., Pruneau, D., & Marceau, F. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(99)00165-4 · Cited by 42
Yokota, C., Kaji, T., Kuge, Y., Inoue, H., Tamaki, N., & Minematsu, K. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.12.109 · Cited by 48
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi‐Nishida, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214459 · Cited by 42
Self-citationSynthesis of prostacyclin and its effect on the contractile activity of the inflamed porcine uterus
Jana, B., JAROSZEWSKI, J. J., Czarzasta, J., Włodarczyk, M., & Markiewicz, W. (2012) · Theriogenology · doi:10.1016/j.theriogenology.2012.10.020 · Cited by 41
Prostacyclin protects vascular integrity via PPAR/14-3-3 pathway
Chu, L.-Y., Liou, J., & Wu, K. K. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.04.006 · Cited by 42
Prostacyclin enhances embryo hatching but not sperm motility
Huang, J.-C., Wun, W.-S. A., Goldsby, J. S., Wun, I. C., Falconi, S. M., & Wu, K. K. (2003) · Human Reproduction · doi:10.1093/humrep/deg490 · Cited by 41
Gene Knockout Mice in the Study of Parturitions
Gross, G., Imamura, T., & Muglia, L. J. (2000) · Journal of the Society for Gynecologic Investigation · doi:10.1177/107155760000700202 · Cited by 40
Selexipag for the treatment of pulmonary arterial hypertension
Skoro‐Sajer, N., & Lang, I. M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.876007 · Cited by 40
“IP receptor deficiency induces thrombus formation and reduces inflammatory and pain responses [17].”
BackgroundPogoriler, J. E., Rich, S., Archer, S. L., & Husain, A. N. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04246.x · Cited by 40
A Novel Subtype of Prostacyclin Receptor in the Central Nervous System
Watanabe, Y., Matsumura, K., Takechi, H., Kato, K., Morii, H., Björkman, M., Långström, B., Noyori, R., Suzuki, M., & Watanabe, Y. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722583.x · Cited by 40
“(3) Recent results from a collaborative study on IP1-knockout mice (Murata et al., 1997) clearly showed the independent expression of IP2 in the CNS of such mice (Y. Watanabe, K. Matsumura, T. Murata, S. Narumiya, M. Suzuki, and Y. Watanabe, in preparation).”
BackgroundPathogenic mechanisms of lipid mediator lysophosphatidic acid in chronic pain
Ueda, H. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101079 · Cited by 40
Cyclooxygenase-2 Inhibitors, Nonsteroidal Anti-inflammatory Drugs, and Cardiovascular Risk
Vardeny, O., & Solomon, S. D. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.06.004 · Cited by 41
“In murine models, deficiency of PGI2 signaling did not result in spontaneous thrombosis, but once the thrombotic process was induced by endothelial damage, it proceeded more vigorously than in mice with intact PGI2 function.(33) The notion that coxibs might be associated with increased risk for thrombosis in humans or…”
BackgroundOsanai, T., Nakamura, M., Sasaki, S., Tomita, H., Saitoh, M., Osawa, H., Yamabe, H., Murakami, S., Magota, K., & Okumura, K. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00334.x · Cited by 40
“Prostacyclin exerts a number of profound effects, including inflammation, thrombogenesis, cell growth, and peripheral circulation [13], and its effect is widespread because prostacyclin receptor is localized in various sites such as heart, aorta, liver, kidney, and brain [14].”
BackgroundPathophysiology of Cyclooxygenases in Cardiovascular Homeostasis
Sellers, R. S., Radi, Z. A., & Khan, N. (2010) · Veterinary Pathology · doi:10.1177/0300985810364389 · Cited by 39
“to vascular injury, they become significantly more prone to thrombotic events, as compared to wild-type (WT) controls.(21,78) Similar to PGI2 receptor–deficient mice, mice overexpressing the TXA2 receptor display increased neointimal hyperplasia, intimal cell proliferation, and platelet activation after mechanical art…”
BackgroundComplete inhibition of purinoceptor agonist-induced nociception by spinorphin, but not by morphine
Ueda, H., Matsunaga, S., Inoue, M., Yamamoto, Y., & Hazato, T. (2000) · Peptides · doi:10.1016/s0196-9781(00)00262-x · Cited by 39
Oberprieler, N. G., Lemeer, S., Kalland, M. E., Torgersen, K. M., Heck, A. J. R., & Taskén, K. (2010) · Blood · doi:10.1182/blood-2010-01-266650 · Cited by 38
Carvalho, J., Chennupati, R., Li, R., Günther, S., Kaur, H., Zhao, W., Tonack, S., Kurz, M. E., Mößlein, N., Bünemann, M., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.043703 · Cited by 40
The roles of small‐molecule inflammatory mediators in rheumatoid arthritis
Cheng, Q., Wu, H., & Du, Y. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12982 · Cited by 41
Cyclooxygenase Metabolites in the Kidney
Harris, R. C., & Zhang, M. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100077 · Cited by 38
Aspirin and Other COX-1 Inhibitors
Patrono, C., & Rocca, B. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-29423-5_6 · Cited by 43
“The first is the observation that mice lacking the PGI2 receptor had increased susceptibility to experimental thrombosis (Murata et al. 1997).”
BackgroundVascular effects of prostacyclin: does activation of PPARδ play a role?
Katušić, Z. S., Santhanam, A. V. R., & He, T. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.05.005 · Cited by 44
“Under basal conditions, IP-deficient mice had normal blood pressure and did not suffer from spontaneous thrombosis (22,23).”
BackgroundMiggin, S. M., & Kinsella, B. T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.w118.004804 · Cited by 38
RetractedNuclear prostaglandin receptors: role in pregnancy and parturition?
Helliwell, R. J. A., Berry, E. B. E., O’Carroll, S. J., & Mitchell, M. D. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.005 · Cited by 43
DeMaria, A. N., & Weir, M. R. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00630-9 · Cited by 45
Höcherl, K., Schmidt, C. G., Kurt, B. Ö., & Bucher, M. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.112029 · Cited by 40
Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2
Kim, R. R., Chen, Z., Mann, T. J., Bastard, K., Scott, K. F., & Church, W. B. (2020) · Molecules · doi:10.3390/molecules25194459 · Cited by 39
“The responses to inflammation and p i were sig ificantly reduced in PGI2 r ceptor knockout mice, which demonstrate that PGI2 is an i p rtant inflammatory mediator [42].”
BackgroundIsono, M., Suzuki, T., Hosono, K., Hayashi, I., Sakagami, H., Uematsu, S., Akira, S., DeClerck, Y. A., Okamoto, H., & Majima, M. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.02.008 · Cited by 37
Takahashi, H. K., Iwagaki, H., Tamura, R., Xue, D., Sano, M., Mori, S., Yoshino, T., Tanaka, N., & Nishibori, M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056432 · Cited by 37
“(Murata et al., 1997) and vasodilator actions, which have”
BackgroundMeyer-Kirchrath, J., Debey, S., Glandorff, C., Kirchrath, L., & Schrör, K. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.07.022 · Cited by 37
Sugita, R., Kuwabara, H., Kubota, K., Sugimoto, K., Kiho, T., Tengeiji, A., Kawakami, K., & Shimada, K. (2016) · Mediators of Inflammation · doi:10.1155/2016/9847840 · Cited by 36
Treutlein, E.-M., Kern, K., Weigert, A., Tarighi, N., Schuh, C., Nüsing, R. M., Schreiber, Y., Ferreirós, N., Brüne, B., Geißlinger, G., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002492 · Cited by 37
“Relative expression of target gene levels were determined using the Ct method, with Ct indicating the cycle number at which the signal of the PCR product crosses a defined threshold set within the exponential phase of the PCR.”
MethodInfluentialProstanoid Signal Integration and Cross Talk
Wise, H. M., Wong, Y. H., & Jones, R. L. (2002) · Neurosignals · doi:10.1159/000057318 · Cited by 36
Vascular biology of eicosanoids and atherogenesis
Praticò, D., & Dogné, J. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.91 · Cited by 37
Prostacyclin mediates neuropathic pain through interleukin 1β-expressing resident macrophages
Schuh, C., Pierre, S. C., Weigert, A., Weichand, B., Altenrath, K., Schreiber, Y., Ferreirós, N., Zhang, D. D., Suo, J., Treutlein, E.-M., et al. (2013) · Pain · doi:10.1016/j.pain.2013.12.006 · Cited by 40
“IP receptor knockout mice [32] were on C57BL/6N background and were compared with age- and sex-matched wild-type mice.”
BackgroundMethodInfluentialKapoor, M., Kojima, F., Qian, M., Yang, L., & Crofford, L. J. (2006) · The FASEB Journal · doi:10.1096/fj.06-6366fje · Cited by 36
Arai, K., Ohno, T., Saeki, T., Mizuguchi, S., Kamata, K., Hayashi, I., Saigenji, K., Murata, T., Narumiya, S., & Majima, M. (2003) · Gut · doi:10.1136/gut.52.9.1242 · Cited by 36
Self-citationGuo, Y., Tukaye, D. N., Wu, W., Zhu, X., Book, M. J., Tan, W. F., Jones, S. P., Rokosh, G. D., Narumiya, S., Li, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041178 · Cited by 38
“Heterozygous IP KO breeding pairs [59] were provided by Dr.”
MethodSelf-citationTunaru, S., Chennupati, R., Nüsing, R. M., & Offermanns, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163633 · Cited by 35
12-HETrE inhibits platelet reactivity and thrombosis in part through the prostacyclin receptor
Tourdot, B. E., Adili, R., Isingizwe, Z. R., Ebrahem, M., Freedman, J. C., Holman, T. R., & Holinstat, M. A. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017006155 · Cited by 35
Divergent roles of prostacyclin and PGE2 in human tendinopathy
Bergqvist, F., Carr, A. J., Wheway, K., Watkins, B., Oppermann, U. C. T., Jakobsson, P., & Dakin, S. G. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1855-5 · Cited by 36
“showed that mice lacking the IP receptor have reduced paw edema and pain sensation when challenged with carrageenan but the mice displayed increased propensities towards thrombosis [13].”
BackgroundLow-Dose Prostacyclin Improves Cortical Perfusion following Experimental Brain Injury in the Rat
Bentzer, P., Venturoli, D., Carlsson, O., & Grände, P. O. (2003) · Journal of Neurotrauma · doi:10.1089/089771503765355522 · Cited by 35
“Its main action in vivo is to inhibit aggregation and adhesion of platelets (Higgs et al., 1978; Murata et al., 1997).”
Popp, L., Häußler, A., Olliges, A., Nüsing, R. M., Narumiya, S., Geißlinger, G., & Tegeder, I. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2008.09.001 · Cited by 35
“All rights reserved. in mutant mice lacking the individual PG receptors (Murata et al., 1997; Minami et al., 2001; Stock et al., 2001) or with EP receptor ligands (Minami et al., 1994b) have not yet provided a coherent picture of which EP receptor(s) is or are involved in nociception.”
BackgroundMethodSelf-citationTP Receptors and Oxidative Stress
Félétou, M., Cohen, R. A., Vanhoutte, P. M., & Verbeuren, T. J. (2010) · Advances in pharmacology · doi:10.1016/b978-0-12-385061-4.00004-0 · Cited by 34
Colville‐Nash, P., & Gilroy, D. W. (2001) · BioDrugs · doi:10.2165/00063030-200115010-00001 · Cited by 41
“In a carrageenin-induced pleurisy and paw swelling model, it was shown recently that the degree of inflammation in prostacyclin receptor-deficient mice was reduced and was comparable to the reduction typically seen when healthy animals received indomethacin.[3] Both PGE2 and prostacyclin are also important in the pain…”
BackgroundDistribution and Cellular Localization of Prostacyclin Synthase in Human Brain
Siegle, I., Klein, T., Zou, M., Fritz, P., & Kömhoff, M. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800507 · Cited by 34
“The biological significance of these findings was recently highlighted by Murata et al. (1997), revealing that IP knockout mice show a decrease in pain perception.”
BackgroundInvestigation of a functional requirement for isoprenylation by the human prostacyclin receptor
Miggin, S. M., Lawler, O. A., & Kinsella, B. T. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2002.02817.x · Cited by 34
Liu, D., Liang, J., Wang, Y., & Zheng, L. (2012) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x11202020098 · Cited by 35
“However, reduced PGI2 activity by genetic deletion of either IP or PGI2 synthase reinforced VSMC proliferation, enhanced platelet activation, increased adhesion of leukocytes on the endothelial cells and then aggravated cardiovascular disorders [25, 38, 39].”
BackgroundDeng, Y., Yang, Z., Terry, T., Su, P., Woodside, D. G., Wang, J., Ruan, K., Willerson, J. T., Dixon, R. A. F., & Liu, Q. (2016) · Nature Communications · doi:10.1038/ncomms11276 · Cited by 33
Prostaglandin terminal synthases as novel therapeutic targets
Hara, S. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.044 · Cited by 35
Mitchell, J. A., Shala, F., Elghazouli, Y., Warner, T. D., Gaston‐Massuet, C., Crescente, M., Armstrong, P. C. J., Herschman, H. R., & Kirkby, N. S. (2019) · Circulation Research · doi:10.1161/circresaha.119.314927 · Cited by 33
“However, it must also be considered that (1) SMCs can produce prostacyclin, albeit in small amounts, (2) that SMCs may outnumber ECs in large arteries, and (3) that the phenotype of SMCs varies between vascular beds.”
BackgroundMethodInfluentialProstacyclin receptor signaling and early embryo development in the mouse
Huang, J.-C., Wun, W.-S. A., Goldsby, J. S., Egan, K. M., FitzGerald, G. A., & Wu, K. K. (2007) · Human Reproduction · doi:10.1093/humrep/dem304 · Cited by 33
“Although the development of IP2/2 embryos was significantly slower than that of WT embryos (Table 1), IP2/2 mice have not been reported to have smaller litters than WT mice (Murata et al., 1997; Cheng et al., 2002).”
BackgroundResultInfluentialCOX-2 inhibitors and cardiovascular risk: Inferences based on biology and clinical studies
Marwali, M., & Mehta, J. L. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-07-0385 · Cited by 38
Jia, Q., Su, W., Peng, W., Li, P., & Wang, Y. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.07.014 · Cited by 33
Sharma, J. S., TURK, J. W., & McHowat, J. (2010) · Biochemistry · doi:10.1021/bi100752u · Cited by 32
“PGI2 also has antithrombotic effects in vivo, and bronchodilator effects on human airways in vitro, although it is less potent than PGE2 in the latter regard (51).”
BackgroundArachidonic Acid Metabolites and the Kidney
Harris, R. C., Breyer, M. D., & BREYER, R. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10013-2 · Cited by 32
Gillio‐Meina, C., Phang, S. H., Mather, J. P., Knight, B. S., & Kennedy, T. G. (2008) · Reproduction · doi:10.1530/rep-08-0294 · Cited by 31
Orie, N. N., Ledwozyw, A., Williams, D. J., Whittle, B. J. R., & Clapp, L. H. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.07.003 · Cited by 36
Signal Transduction During Platelet Plug Formation
Brass, L. F., Stalker, T. J., Zhu, L., & Woulfe, D. S. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50778-3 · Cited by 31
Hay, C., & de Belleroche, J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00073-2 · Cited by 31
Metadata
- Authors
- Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S., & Narumiya, S.
- Affiliations
- Kyoto University (JP)
- Ono Pharmaceutical (Japan) (JP)
- Osaka Women's and Children's Hospital (JP)
- Kitasato University (JP)
- Corresponding author
- Narumiya, Shuh
- Venue
- Nature
- Published
- 1997-08-14
- Volume
- 388
- Issue
- 6643
- Pages
- 678-682
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1666619344
- Cited by
- 773
- References
- 27
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 14 · 2020: 15 · 2019: 21 · 2018: 14 · 2017: 23 · 2016: 18 · 2015: 29 · 2014: 17 · 2013: 21 · 2012: 33
- FWCI
- 25.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- prostacyclin receptor, prostacyclin, prostanoids, pain perception, inflammation, thrombosis, indomethacin, prostaglandins, thromboxane, knockout mice, antithrombotic agents, vascular homeostasis
- MeSH terms
- Animals, Antithrombins, Blood Pressure, Inflammation, Mice, Inbred C57BL, Pain, Platelet Aggregation, Epoprostenol, Receptors, Prostaglandin, Thrombosis, Restriction Mapping, Dinoprostone, Mutagenesis, Gene Targeting, Receptors, Epoprostenol, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.